UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts

Molecular pharmaceutics, 2018-04, Vol.15 (4), p.1392-1402

2018

Volltextzugriff (PDF)

Abstract P6-13-07: The taccalonolides are novel microtubule stabilizers that covalently bind tubulin and have in vivo efficacy in drug resistant tumors

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-13-07

2016

Volltextzugriff (PDF)

Abstract P6-17-26: Care 001: multi-center randomized open-label phase II trial of neoadjuvant trastuzumab emtansine (T-DM1) in combination with lapatinib and nab-paclitaxel compared with paclitaxel, trastuzumab and pertuzumab in HER2-neu over-expressed breast cancer patients (TEAL study)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-17-26

2019

Volltextzugriff (PDF)

Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01

Clinical cancer research, 2005-11, Vol.11 (21), p.7841-7850

2005

Volltextzugriff (PDF)

Does intraosseous equal intravenous? A pharmacokinetic study

The American journal of emergency medicine, 2008, Vol.26 (1), p.31-38

2008

Volltextzugriff (PDF)

Suppression of Mammary Tumorigenesis in Transgenic Mice by the RXR-selective Retinoid, LGD1069

Cancer epidemiology, biomarkers & prevention, 2002-05, Vol.11 (5), p.467-474

2002

Volltextzugriff (PDF)

Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report

Oncology (Williston Park, N.Y.), 2002-08, Vol.16 (8 Suppl 7), p.33

Kuhn, John G

2002

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Col-3 (Metastat), an Oral Tetracycline Derivative with Potent Matrix Metalloproteinase and Antitumor Properties

Clinical cancer research, 2004-10, Vol.10 (19), p.6512-6521

2004

Volltextzugriff (PDF)

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4282-4289

2004

Volltextzugriff (PDF)

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1128-1135

1996

Volltextzugriff (PDF)

Fluorouracil and the new oral fluorinated pyrimidines

The Annals of pharmacotherapy, 2001-02, Vol.35 (2), p.217-227

Kuhn, J G

2001

Volltextzugriff (PDF)

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Cancer chemotherapy and pharmacology, 1999, Vol.44 (5), p.372-380

1999

Volltextzugriff (PDF)

Chemotherapy-associated hematopoietic toxicity

American journal of health-system pharmacy, 2002-08, Vol.59 (15 Suppl 4), p.S4-S7

Kuhn, John G

2002

Volltextzugriff (PDF)

A phase ii study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: A North American Brain Tumor Consortium Report

Cancer, 2001-01, Vol.91 (2), p.417-422

2001

Volltextzugriff (PDF)

Phase I and pharmacokinetic trial of weekly CPT-11

Journal of clinical oncology, 1993-11, Vol.11 (11), p.2194-2204

1993

Volltextzugriff (PDF)

Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.1977-1983

2003

Volltextzugriff (PDF)

Pharmacology of irinotecan

Oncology (Williston Park, N.Y.), 1998-08, Vol.12 (8 Suppl 6), p.39

Kuhn, J G

1998

Volltextzugriff (PDF)

Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion

Thrombosis and haemostasis, 2003-05, Vol.89 (5), p.803-811

2003

Volltextzugriff (PDF)

Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy

Breast cancer research and treatment, 2006, Vol.95 (1), p.13-16

2006

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

Journal of clinical oncology, 1999-02, Vol.17 (2), p.685-696

1999

Volltextzugriff (PDF)

9-cis-Retinoic Acid Suppresses Mammary Tumorigenesis in C3(1)-Simian Virus 40 T Antigen-transgenic Mice

Clinical cancer research, 2000-09, Vol.6 (9), p.3696-3704

2000

Volltextzugriff (PDF)

A Randomized Phase I and Pharmacological Trial of Sequences of 1,3-bis(2-Chloroethyl)-1-Nitrosourea and Temozolomide in Patients with Advanced Solid Neoplasms

Clinical cancer research, 2004-03, Vol.10 (5), p.1645-1656

2004

Volltextzugriff (PDF)

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2188-2194

1998

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-12, Vol.11 (24), p.8728-8736

2005

Volltextzugriff (PDF)

Effects of Hydroxyurea on Extrachromosomal DNA in Patients with Advanced Ovarian Carcinomas

Clinical cancer research, 2001-05, Vol.7 (5), p.1171-1180

2001

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(152)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts

Abstract P6-13-07: The taccalonolides are novel microtubule stabilizers that covalently bind tubulin and have in vivo efficacy in drug resistant tumors

Abstract P6-17-26: Care 001: multi-center randomized open-label phase II trial of neoadjuvant trastuzumab emtansine (T-DM1) in combination with lapatinib and nab-paclitaxel compared with paclitaxel, trastuzumab and pertuzumab in HER2-neu over-expressed breast cancer patients (TEAL study)

Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01

Does intraosseous equal intravenous? A pharmacokinetic study

Suppression of Mammary Tumorigenesis in Transgenic Mice by the RXR-selective Retinoid, LGD1069

Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report

A Phase I and Pharmacokinetic Study of Col-3 (Metastat), an Oral Tetracycline Derivative with Potent Matrix Metalloproteinase and Antitumor Properties

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer

Fluorouracil and the new oral fluorinated pyrimidines

A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Chemotherapy-associated hematopoietic toxicity

A phase ii study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: A North American Brain Tumor Consortium Report

Phase I and pharmacokinetic trial of weekly CPT-11

Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)

Pharmacology of irinotecan

Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion

Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors

9-cis-Retinoic Acid Suppresses Mammary Tumorigenesis in C3(1)-Simian Virus 40 T Antigen-transgenic Mice

A Randomized Phase I and Pharmacological Trial of Sequences of 1,3-bis(2-Chloroethyl)-1-Nitrosourea and Temozolomide in Patients with Advanced Solid Neoplasms

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Effects of Hydroxyurea on Extrachromosomal DNA in Patients with Advanced Ovarian Carcinomas

Suchergebnisse filtern